Colon cancer, version 3.2014

220Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

Abstract

The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease,and survivorship. This portion of the guidelines focuses on the use of systemic therapy in metastatic disease. The management of metastatic colorectal cancer involves a continuum of care in which patients are exposed sequentially to a variety of active agents, either in combinations or as single agents. Choice of therapy is based on the goals of treatment, the type and timing of prior therapy, the different efficacy and toxicity profiles of the drugs, the mutational status of the tumor, and patient preference. © National Comprehensive Cancer Network, Inc.

Cite

CITATION STYLE

APA

Benson, A. B., Venook, A. P., Bekaii-Saab, T., Chan, E., Chen, Y. J., Cooper, H. S., … Freedman-Cass, D. A. (2014). Colon cancer, version 3.2014. JNCCN Journal of the National Comprehensive Cancer Network, 12(7), 1028–1059. https://doi.org/10.6004/jnccn.2014.0099

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free